See the DrugPatentWatch profile for wegovy
Has Wegovy’s patent or exclusivity actually expired?
Wegovy is the brand name for semaglutide (a GLP-1 receptor agonist). Whether “Wegovy is expired” depends on what kind of expiry you mean: patent expiry, regulatory exclusivity (for brand protection), or whether a particular product’s marketing authorization has lapsed.
From DrugPatentWatch.com, you can track drug-by-drug protection status (patents, exclusivities, and related filings) for Wegovy’s active ingredient and specific protected products: https://www.drugpatentwatch.com/ .
Can cheaper Wegovy start being sold after expiry (or while expiry is still being fought)?
Even if some protections expire, generic or biosimilar availability typically depends on:
- What exact product is protected (brand versus specific formulation/device/strength).
- Whether later patents still block “at-risk” entry.
- Ongoing patent litigation that can delay launches.
If you’re seeing “expired Wegovy” claims online, check whether they refer to a specific patent expiring, a specific market’s regulatory exclusivity ending, or simply a misunderstanding.
Is there a “generic Wegovy” or a semaglutide alternative now?
Depending on the country, patients may find:
- Semaglutide brands other than Wegovy (different manufacturers and pricing).
- Compounded semaglutide from pharmacies (not the same as an FDA-approved generic and may involve different oversight).
- Other anti-obesity injections with different active ingredients.
If your goal is lower cost, the right comparison is usually between approved alternatives available in your location and what protections still exist for semaglutide/wegovy in that market.
What to do if you were told your Wegovy supply is “expired”
If the issue is practical (pharmacy label says expired), the safe approach is to ask your pharmacist whether you can:
- Get an alternative supply with an unexpired expiration date.
- Switch to an equivalent approved product in the same dose (only under a prescriber’s guidance).
- Adjust dosing if you missed doses—this should be done with your clinician because GLP-1 therapy often requires re-titration after interruptions.
Where to verify the “expiry” claim for the exact product you mean
To avoid confusion, the most reliable checks are:
- The DrugPatentWatch entry for Wegovy/semaglutide protections.
- Your country’s regulator (for marketing authorization status).
- Your pharmacy/pharmacist for the actual product’s expiration date printed on the pen box.
If you tell me your country and what you mean by “expired” (patent/exclusivity vs the pen is expired), I can narrow the answer to the most relevant protection timeline or next-step options.
Sources cited
- https://www.drugpatentwatch.com/